TRACON Pharmaceuticals (TCON) News Today → weirdest stock market marches on (From DTI) (Ad) Free TCON Stock Alerts $1.43 -0.10 (-6.54%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 18 at 3:50 AM | americanbankingnews.comTRACON Pharmaceuticals (NASDAQ:TCON) Lowered to Hold at StockNews.comMay 15, 2024 | msn.comTRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Q1 2024 Earnings Call TranscriptMay 15, 2024 | finance.yahoo.comQ1 2024 TRACON Pharmaceuticals Inc Earnings CallMay 15, 2024 | finance.yahoo.comTRACON Pharmaceuticals Inc (TCON) Q1 2024 Earnings Call Transcript Highlights: Strategic ...May 14, 2024 | investorplace.comTCON Stock Earnings: TRACON Pharma Misses EPS for Q1 2024May 14, 2024 | finance.yahoo.comTRACON Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate UpdateMay 14, 2024 | globenewswire.comTRACON Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate UpdateMay 12, 2024 | americanbankingnews.comTRACON Pharmaceuticals (NASDAQ:TCON) Rating Lowered to Buy at StockNews.comMay 12, 2024 | americanbankingnews.comTRACON Pharmaceuticals (TCON) to Release Quarterly Earnings on TuesdayMay 7, 2024 | globenewswire.comTRACON to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024April 26, 2024 | money.usnews.comTRACON Pharmaceuticals IncApril 11, 2024 | marketbeat.comTRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Sees Significant Drop in Short InterestTRACON Pharmaceuticals, Inc. (NASDAQ:TCON - Get Free Report) saw a large drop in short interest in March. As of March 31st, there was short interest totalling 744,900 shares, a drop of 60.8% from the March 15th total of 1,900,000 shares. Based on an average daily volume of 3,400,000 shares, the short-interest ratio is presently 0.2 days.April 10, 2024 | markets.businessinsider.comBuy Rating Reaffirmed for TRACON Pharmaceuticals Post-Reverse Split and Envafolimab Valuation UpdateApril 10, 2024 | uk.investing.comTRACON announces 1-for-20 reverse stock splitApril 10, 2024 | investorplace.comWall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for April 2024April 10, 2024 | marketbeat.comTrading was temporarily halted for "TCON" at 07:04 PM with a stated reason of "News pending."April 8, 2024 | marketwatch.comShares of Tracon Pharmaceuticals Tumble 22% on Reverse SplitApril 8, 2024 | finanznachrichten.deTRACON Pharmaceuticals, Inc.: TRACON Pharmaceuticals Announces Reverse Stock SplitApril 8, 2024 | globenewswire.comTRACON Pharmaceuticals Announces Reverse Stock SplitApril 4, 2024 | markets.businessinsider.comBuy Rating Affirmed for TRACON Pharmaceuticals Amid Promising Envafolimab Trial OutlookApril 3, 2024 | msn.comTracon Pharma drops after pivotal data for cancer drugApril 3, 2024 | finance.yahoo.comTRACON Pharmaceuticals Provides Update on Ongoing ENVASARC Phase 2 Pivotal Trial Following Independent Data Monitoring Committee Recommendation to Continue the Trial as PlannedMarch 13, 2024 | markets.businessinsider.comJonesTrading Reaffirms Their Hold Rating on TRACON Pharmaceuticals (TCON)March 8, 2024 | markets.businessinsider.comBuy Rating for TRACON Pharmaceuticals on Strong Financials and Promising Clinical TrialsMarch 7, 2024 | finanznachrichten.deTRACON Pharmaceuticals, Inc.: TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate UpdateMarch 7, 2024 | seekingalpha.comTRACON Pharmaceuticals, Inc. (TCON) Q4 2023 Earnings Call TranscriptMarch 7, 2024 | finance.yahoo.comTRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Q4 2023 Earnings Call TranscriptMarch 5, 2024 | globenewswire.comTRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate UpdateMarch 4, 2024 | msn.comTracon Q4 2023 Earnings PreviewMarch 4, 2024 | benzinga.comA Preview Of TRACON Pharma's EarningsFebruary 28, 2024 | globenewswire.comTRACON to Report Fourth Quarter and Year-End 2023 Financial Results and Provide Corporate Update on March 5, 2024February 13, 2024 | finance.yahoo.comTRACON Pharmaceuticals, Inc. (TCON)December 23, 2023 | benzinga.comTRACON Pharma Stock (NASDAQ:TCON), Guidance and ForecastDecember 21, 2023 | markets.businessinsider.comBuy Rating for TRACON Pharmaceuticals on Envafolimab’s Promising Trial Outcomes and Strong Market PotentialNovember 25, 2023 | seekingalpha.comTCON TRACON Pharmaceuticals, Inc.November 21, 2023 | msn.comWhy Is Tracon Pharmaceuticals (TCON) Stock Up 19% Today?November 21, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: TRACON Pharmaceuticals (TCON), Anavex Life Sciences (AVXL) and Genmab (GMAB)November 20, 2023 | finance.yahoo.comTRACON Pharmaceuticals Announces License of Product Development Platform for $3.0 Million Upfront PaymentNovember 15, 2023 | markets.businessinsider.comPromising Financial and Clinical Prospects Bolster Buy Rating for TRACON PharmaceuticalsNovember 12, 2023 | finance.yahoo.comTRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Q3 2023 Earnings Call TranscriptNovember 10, 2023 | finanznachrichten.deTRACON Pharmaceuticals, Inc.: TRACON Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNovember 9, 2023 | finance.yahoo.comTRACON Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNovember 1, 2023 | msn.comTRACON Pharmaceuticals (TCON) Price Target Increased by 21.88% to 6.63November 1, 2023 | morningstar.comTRACON Pharmaceuticals Inc TCONOctober 31, 2023 | finance.yahoo.comTRACON to Report Third Quarter 2023 Financial Results and Provide Corporate Update on November 9, 2023October 27, 2023 | benzinga.comWhy Intel Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving PremarketSeptember 18, 2023 | finance.yahoo.comTRACON Pharmaceuticals Announces ENVASARC Phase 2 Pivotal Trial Exceeded Futility Threshold at Final Interim Analysis and Will Continue as PlannedSeptember 2, 2023 | finance.yahoo.com7 F-Rated Biotech Stocks You Shouldn’t Touch With a 10-Foot PoleAugust 22, 2023 | msn.comJonesTrading Downgrades TRACON Pharmaceuticals (TCON)August 18, 2023 | finance.yahoo.comTCON Aug 2023 2.500 call Get TRACON Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TCON and its competitors with MarketBeat's FREE daily newsletter. Email Address Free report reveals “two-baggers” for 2024 (Ad)We’ve put together something special for our subscribers — a free report on 5 stocks we believe could double in 2024. It’s straightforward, easy to understand, and most importantly, actionable. Download your free report today! TCON Media Mentions By Week TCON Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TCON News Sentiment▼-0.100.42▲Average Medical News Sentiment TCON News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TCON Articles This Week▼81▲TCON Articles Average Week Get TRACON Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TCON and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: TC Biopharm News Today Fresh Tracks Therapeutics News Today Kiromic BioPharma News Today Finch Therapeutics Group News Today Palisade Bio News Today Titan Pharmaceuticals News Today Avalon GloboCare News Today Creative Medical Technology News Today Eloxx Pharmaceuticals News Today Windtree Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TCON) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressMost important medical advance in 100 yearsThe Oxford ClubUrgent Nvidia WarningAltimetryShocking $16T Elon Musk Crypto LeakCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingNext President (Not Trump. Not Biden.)The Freeport Society41 banks launch ‘crypto dollar’Stansberry ResearchWhat’s Really Next for America…Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TRACON Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
